Seneciphylline
Based on 1 Customer Validation
Seneciphylline is an orally effective hepatotoxic inducer. Seneciphylline is metabolized by CYP450 enzymes into active intermediates, which covalently bind to intracellular biomacromolecules such as proteins and DNA to form adducts, which in turn trigger a series of toxic reactions, such as inducing cell apoptosis and damaging mitochondrial function. Seneciphylline can be used in hepatotoxicity research
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.93%
- CAS No.: 480-81-9
- Formule: C18H23NO5
- Masse moléculaire:333.38
-
Stockage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Antioxidant Compound Library
HY-L037
-
Macrocyclic Compound Library
HY-L041
-
Oxygen Sensing Compound Library
HY-L045
-
Orally Active Compound Library
HY-L061
-
Alkaloids Library
HY-L071
-
Mitochondria-Targeted Compound Library
HY-L089
-
Anti-Cancer Natural Product Library
HY-L107
-
Plant-Sourced Natural Product Library
HY-L115
-
Metabolic Enzyme Compound Library
HY-L146
-
Radioprotector Library
HY-L178
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Bioactive Compound Library
HY-L001
-
Amino Acid Metabolism Compound Library
HY-L189
-
RO5 Drug-like Natural Product Library
HY-L200
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Natural Product Diversity Scaffold Library
HY-L245
-
Mass Spectrometry Natural Product Library
HY-L262
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Metabolism/Protease Compound Library
HY-L012
-
Natural Product Library
HY-L021
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
>100 μg/mL
Compound: 5
|
Toxicity against Cricetulus griseus CHO (Chinese hamster ovary) cell by MTT assay
Toxicity against Cricetulus griseus CHO (Chinese hamster ovary) cell by MTT assay
|
10.1016/jbse.2007.08.015 |
| Sf9 | EC50 |
>100 μg/mL
Compound: 5
|
Toxicity against Spodoptera frugiperda (fall armyworm) Sf9 cells by MTT assay
Toxicity against Spodoptera frugiperda (fall armyworm) Sf9 cells by MTT assay
|
10.1016/jbse.2007.08.015 |
Seneciphylline (10-1000 μM) slightly stimulates rat liver microsomal epoxide hydrolase, has no significant effect on glutathione-S-transferase, and has no significant effect on the activities of aminopyrine demethylase and aryl hydrocarbon hydroxylase (AHH) [1].
Seneciphylline (5-50 μM; 6-24 h) reduces the viability of primary mouse and human hepatocytes and induces apoptosis in a time-and dose-dependent manner. Seneciphylline (5-20 μM; 6-12 h) increases the content of pyrrole-protein adducts (PPA) in primary mouse hepatocytes in a time-and dose-dependent manner[2].
In primary hepatocyte mitochondrial experiments, Seneciphylline (20 μM) induces changes in the morphology of primary mouse hepatocyte mitochondria, making them rounder and shorter, losing mitochondrial membrane potential (MMP)，releasing cytochrome Cyt c from mitochondria to the cytoplasm, and increasing JNK phosphorylation levels[2].
Seneciphylline (20 μM; 24 hours) -induced apoptosis in primary mouse hepatocytes was effectively inhibited by 50 μM Mdivi-1 (HY-15886). Mdivi-1 also inhibits Seph-induced mitochondrial depolarization, reduces the number of apoptotic nuclei, reduces the proportion of cells with MMP loss, reduced the level of Cyt c protein in the cytoplasm, and inhibits the cleavage and activation of Caspase-3[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Primary mouse hepatocytes, Primary human hepatocytes
-
Concentration:5-50 μM for cell viability and apoptosis assays
-
Incubation Time:6-24 h for cell viability and apoptosis assays
-
Result:Decreased cell viability in a dose-and time-dependent manner.
Induced apoptosis in a time-and dose-dependent manner. After treatment with 5 μM for 24 h, the apoptotic cell rate was 26.6%, and it increased to 47.7% when treated with 20 μM Seph.
When treated with 20 μM Seph for 12 h, the apoptotic cell rate was 21.3%, and it was higher at 24 h.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57BL/6 J mice (20-22 g)[2]
-
Dosage:70 mg/kg (dissolved in acidified 0.9% NaCl with pH 6.5).
-
Administration:Oral administration, single dose.
-
Result:Resulted severe liver injury. H&E staining of liver tissues revealed inflammation, apoptosis, and sinusoid hemorrhage.
Significantly elevated the serum levels of ALT, AST, TBIL, and TBA compared with the control group.
Increased pro-inflammatory cytokines, including TNF-α, IL-1β.
Resulted a dramatic increase in hepatic parenchymal cell apoptosis in TUNEL staining.
Increased cleaved Caspase-3 level, and caspase-3 activity in the liver, indicating that Seneciphylline induced apoptosis in the liver.
Chemical Information
-
CAS No. 480-81-9
-
Appearance Solid
-
Masse moléculaire 333.38
-
Formule C18H23NO5
-
Color White to off-white
-
SMILES
O=C(O[C@]1([H])CCN2[C@]1([H])C(COC([C@](C)(O)C(C/3)=C)=O)=CC2)C3=C/C
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvant et solubilité
DMSO : 7.69 mg/mL (23.07 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 0.77 mg/mL (2.31 mM); Clear solution
This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 0.77 mg/mL (2.31 mM); Clear solution
This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation
-
Fiche technique (289 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Korean - KR (480 KB)
- Portuguese - PT (480 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Kakrani HK, et al. Effect of seneciphylline and senecionine on hepatic drug metabolizing enzymes in rats. J Ethnopharmacol. 1984 Dec;12 (3) :271-8. [Content Brief]
[2]. Wang W, et al. Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis. J Appl Toxicol. 2020 Nov;40 (11) :1534-1544. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.9996 mL | 14.9979 mL | 29.9958 mL | 74.9895 mL |
| 5 mM | 0.5999 mL | 2.9996 mL | 5.9992 mL | 14.9979 mL | |
| 10 mM | 0.3000 mL | 1.4998 mL | 2.9996 mL | 7.4990 mL | |
| 15 mM | 0.2000 mL | 0.9999 mL | 1.9997 mL | 4.9993 mL | |
| 20 mM | 0.1500 mL | 0.7499 mL | 1.4998 mL | 3.7495 mL |
Seneciphylline Related Classifications
HY-N1282 Related Classifications
Powered by Bioz